BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19930665)

  • 1. Inflammatory bowel disease serologies in ankylosing spondylitis patients: a pilot study.
    Mundwiler ML; Mei L; Landers CJ; Reveille JD; Targan S; Weisman MH
    Arthritis Res Ther; 2009; 11(6):R177. PubMed ID: 19930665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated serum anti-flagellin antibodies implicate subclinical bowel inflammation in ankylosing spondylitis: an observational study.
    Wallis D; Asaduzzaman A; Weisman M; Haroon N; Anton A; McGovern D; Targan S; Inman R
    Arthritis Res Ther; 2013 Oct; 15(5):R166. PubMed ID: 24286190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Markers of intestinal inflammation in patients with ankylosing spondylitis: a pilot study.
    Matzkies FG; Targan SR; Berel D; Landers CJ; Reveille JD; McGovern DP; Weisman MH
    Arthritis Res Ther; 2012 Nov; 14(6):R261. PubMed ID: 23194008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
    Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A
    Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concordance in Anti-OmpC and Anti-I2 Indicate the Influence of Genetic Predisposition: Results of a European Study of Twins with Crohn's Disease.
    Amcoff K; Joossens M; Pierik MJ; Jonkers D; Bohr J; Joossens S; Romberg-Camps M; Nyhlin N; Wickbom A; Rutgeerts PJ; Tysk C; Bodin L; Colombel JF; Vermeire S; Halfvarson J
    J Crohns Colitis; 2016 Jun; 10(6):695-702. PubMed ID: 26818662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relevance of serologic studies in inflammatory bowel diseases].
    Papp M; Altorjay I; Lakatos PL
    Orv Hetil; 2007 May; 148(19):887-96. PubMed ID: 17478404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to Escherichia coli outer membrane porin C in the absence of anti-Saccharomyces cerevisiae antibodies and anti-neutrophil cytoplasmic antibodies are an unreliable marker of Crohn disease and ulcerative colitis.
    Davis MK; Andres JM; Jolley CD; Novak DA; Haafiz AB; González-Peralta RP
    J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):409-13. PubMed ID: 18030205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pANCA, ASCA, and OmpC antibodies in patients with ankylosing spondylitis without inflammatory bowel disease.
    de Vries M; van der Horst-Bruinsma I; van Hoogstraten I; van Bodegraven A; von Blomberg BM; Ratnawati H; Dijkmans B
    J Rheumatol; 2010 Nov; 37(11):2340-4. PubMed ID: 20810508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory Bowel Disease Serological Immune Markers Anti-Saccharomyces cerevisiae Mannan Antibodies and Outer Membrane Porin C are Potential Biomarkers for Hirschsprung-associated Enterocolitis.
    Frykman PK; Patel DC; Kim S; Cheng Z; Wester T; Nordenskjöld A; Kawaguchi A; Hui TT; Ehrlich PF; Granström AL; Benliyan F;
    J Pediatr Gastroenterol Nutr; 2019 Aug; 69(2):176-181. PubMed ID: 30964819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease.
    Mow WS; Vasiliauskas EA; Lin YC; Fleshner PR; Papadakis KA; Taylor KD; Landers CJ; Abreu-Martin MT; Rotter JI; Yang H; Targan SR
    Gastroenterology; 2004 Feb; 126(2):414-24. PubMed ID: 14762777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serological antibodies and surgery in a population-based inception cohort of Crohn's disease patients - the IBSEN study.
    Kristensen VA; Cvancarova M; Høivik ML; Moum B; Vatn MH
    Scand J Gastroenterol; 2020 Apr; 55(4):436-441. PubMed ID: 32252542
    [No Abstract]   [Full Text] [Related]  

  • 12. Diagnostic role and clinical correlates of anti-Saccharomyces cerevisiae antibodies (ASCA) and anti-neutrophil cytoplasmic antibodies (p-ANCA) in Italian patients with inflammatory bowel diseases.
    Saibeni S; Folli C; de Franchis R; Borsi G; Vecchi M
    Dig Liver Dis; 2003 Dec; 35(12):862-8. PubMed ID: 14703881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High levels of Crohn's disease-associated anti-microbial antibodies are present and independent of colitis in chronic granulomatous disease.
    Yu JE; De Ravin SS; Uzel G; Landers C; Targan S; Malech HL; Holland SM; Cao W; Harpaz N; Mayer L; Cunningham-Rundles C
    Clin Immunol; 2011 Jan; 138(1):14-22. PubMed ID: 20956091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic role and clinical association of ASCA and ANCA in Brazilian patients with inflammatory bowel disease.
    Nisihara RM; de Carvalho WB; Utiyama SR; Amarante H; Baptista ML
    Dig Dis Sci; 2010 Aug; 55(8):2309-15. PubMed ID: 19826949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroreactivity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients.
    Papp M; Altorjay I; Norman GL; Shums Z; Palatka K; Vitalis Z; Foldi I; Lakos G; Tumpek J; Udvardy ML; Harsfalvi J; Fischer S; Lakatos L; Kovacs A; Bene L; Molnar T; Tulassay Z; Miheller P; Veres G; Papp J; ; Lakatos PL
    Inflamm Bowel Dis; 2007 Aug; 13(8):984-92. PubMed ID: 17417801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological markers in diagnosis of pediatric inflammatory bowel disease and as predictors for early tumor necrosis factor blocker therapy.
    Olbjørn C; Cvancarova Småstuen M; Thiis-Evensen E; Nakstad B; Vatn MH; Perminow G
    Scand J Gastroenterol; 2017 Apr; 52(4):414-419. PubMed ID: 27887202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of serum antibodies in patients suspected of having inflammatory bowel disease.
    Jaskowski TD; Litwin CM; Hill HR
    Clin Vaccine Immunol; 2006 Jun; 13(6):655-60. PubMed ID: 16760323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens.
    Landers CJ; Cohavy O; Misra R; Yang H; Lin YC; Braun J; Targan SR
    Gastroenterology; 2002 Sep; 123(3):689-99. PubMed ID: 12198693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical significance of antimicrobial serologic responses within an Irish Crohn's disease population.
    O'Donnell S; O'Sullivan M; O'Morain CA; Ryan BM
    Eur J Gastroenterol Hepatol; 2013 Dec; 25(12):1464-9. PubMed ID: 24047859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serological markers for inflammatory bowel disease in AIDS patients with evidence of microbial translocation.
    Kamat A; Ancuta P; Blumberg RS; Gabuzda D
    PLoS One; 2010 Nov; 5(11):e15533. PubMed ID: 21125014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.